凯莱英(06821)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

06821 凯莱英

收市竞价 07-02 16:07:36

106.900

-1.900

-1.75%

最高117.700	最低105.900	成交量122.32万
今开112.000	昨收108.800	日振幅10.85%
总市值385.91亿	流通市值29.45亿	总股本3.61亿
成交额1.34亿	换手率4.44%	流通股本2,755万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"06821","market":"HK","secType":"STK","nameCN":"凯莱英","latestPrice":106.9,"timestamp":1782979645720,"preClose":108.8,"halted":0,"volume":1223166,"delay":0,"changeRate":-0.017463235294117568,"floatShares":27553260,"shares":361000000,"eps":3.16,"marketStatus":"收市竞价","change":-1.9,"latestTime":"07-02 16:07:36","open":112,"high":117.7,"low":105.9,"amount":134482993,"amplitude":0.108456,"askPrice":106.9,"askSize":3100,"bidPrice":106.9,"bidSize":3300,"shortable":3,"etf":0,"ttmEps":3.53274,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1782979800000},"marketStatusCode":4,"adr":0,"listingDate":1639065600000,"exchange":"SEHK","adjPreClose":108.8,"dividendRate":0.014042,"openAndCloseTimeList":[[1782955800000,1782964800000],[1782968400000,1782979200000]],"volumeRatio":0.818568,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"002821","market":"SZ","secType":"STK","nameCN":"凯莱英","latestPrice":153.19,"timestamp":1782975600000,"preClose":164.8,"halted":0,"volume":19579100,"delay":0,"premium":"-39.59"}},"requestUrl":"/m/hq/s/06821","defaultTab":"news","newsList":[{"id":"2647386322","title":"凯莱英创60日新高，开源证券二个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2647386322","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647386322?lang=zh_cn&edition=full","pubTime":"2026-06-29 16:43","pubTimestamp":1782722609,"startTime":"0","endTime":"0","summary":"今日凯莱英创60日新高，收盘报167.75元。2026年4月1日，开源证券研究员余汝意发布了对凯莱英的研报《公司信息更新报告：收入利润高质增长，多赛道景气共振下迈向加速周期》，该研报对凯莱英给出“买入”评级。研报中预计2026-2028年公司归母净利润为15.07/18.59/23.12亿元，EPS为4.18/5.15/6.41元，当前股价对应PE为24.1/19.5/15.7倍，维持“买入”评级。凯莱英个股概况：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062900024586.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["06821","161027","002821"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647326829","title":"港股CRO概念股涨幅居前 凯莱英涨10.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2647326829","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647326829?lang=zh_cn&edition=full","pubTime":"2026-06-29 14:38","pubTimestamp":1782715096,"startTime":"0","endTime":"0","summary":"6月29日，港股CRO概念股涨幅居前，截至发稿，凯莱英(06821.HK)涨10.69%，报123.2港元；昭衍新药(06127.HK)涨8.11%，报19.59港元；药明生物(02269.HK)涨6.9%，报35.32港元；药明康德(02359.HK)涨5.78%，报153.8港元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202606293786547646.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606293786547646.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["VXUS","BK0239","002821","BK4588","LU1328615791.USD","BK0132","BK4585","BK1191","06821"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647325211","title":"港股异动 | CRO概念股涨幅居前 长期看AI将引发行业变革 研发端或分化而生产端整体受益","url":"https://stock-news.laohu8.com/highlight/detail?id=2647325211","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647325211?lang=zh_cn&edition=full","pubTime":"2026-06-29 14:28","pubTimestamp":1782714533,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU1046422090.SGD","LU0326950275.SGD","LU1794554557.SGD","LU0307460666.USD","02359","LU2125910500.SGD","BK1583","BK1191","LU0708995583.HKD","LU0823426308.USD","LU0516423174.USD","LU2242644610.SGD","LU0043850808.USD","LU0823426480.USD","SG9999002463.SGD","LU3063872942.SGD","LU0516422952.EUR","LU0327786744.USD","LU0417516738.SGD","BK1589","LU0140636845.USD","LU1880383366.USD","LU0516422440.USD","06821","LU0516423091.SGD","LU2045819591.USD","SG9999002562.SGD","IE00B0JY6N72.USD","LU0359202008.SGD","LU1720050803.USD","LU0572944931.SGD","LU2039709279.SGD","LU0039217434.USD","LU1688375341.USD","LU0588546209.SGD","LU0456827905.SGD","LU1242518857.USD","06127","LU0052750758.USD","LU0819121731.USD","BK1521","LU0348766576.USD","LU0359201612.USD","LU0456846285.SGD","LU0516422366.SGD","02269","LU0856984785.SGD","LU0417516902.SGD","LU0051755006.USD","LU0979878070.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647347358","title":"创新药板块逆市大涨！凯莱英、海南海药等近十只涨停，多股涨超10%！_手机新浪网","url":"https://stock-news.laohu8.com/highlight/detail?id=2647347358","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647347358?lang=zh_cn&edition=full","pubTime":"2026-06-29 10:34","pubTimestamp":1782700446,"startTime":"0","endTime":"0","summary":"创新药板块逆市大涨！凯莱英、海南海药等近十只涨停，多股涨超10%！    分时图\r\n\r\n　　创新药板块逆市大涨，凯莱英、海南海药、太龙药业、新华制药、双鹭药业等近十只涨停，新赣江逼近涨停，三生国健、益方生物、睿智医药、佰仁医疗、艾迪药业、荣昌生物、舒泰神、圣诺生物、百利天恒涨超10%，赛升药业、诺思兰德、康龙化成、贝达药业、诺诚健华跟涨。\r\n\r\n　　消息面上，国家医保局6月29日对通过2026年目录初审的药品名单和主要信息进行公示，其中557个、54个药品分别通过基本医保药品目录、商保创新药目录初步形式审查。","market":"us","thumbnail":" http://caiji.3g.cnfol.com/colect/202606/29/20260629655429.jpg","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202606/29/20260629655429.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/shichangceping/20260629/32292729.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK1161","BK0188","BK0060","SINA","002821","BK0070","BK0239","BK1574","06978","06821","LU1328615791.USD","BK1191","BK0146","000566","159992","BK0132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647134271","title":"异动快报：凯莱英（002821）6月29日10点18分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2647134271","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647134271?lang=zh_cn&edition=full","pubTime":"2026-06-29 10:20","pubTimestamp":1782699656,"startTime":"0","endTime":"0","summary":"证券之星6月29日盘中消息，10点18分凯莱英（002821）触及涨停板。其所属行业医疗服务目前上涨。领涨股为万邦医药。该股为减肥药，创新药，健康中国概念热股，当日减肥药概念上涨5.43%，创新药概念上涨3.99%，健康中国概念上涨3.69%。6月26日的资金流向数据方面，主力资金净流出1.94亿元，占总成交额9.07%，游资资金净流出527.14万元，占总成交额0.25%，散户资金净流入1.99亿元，占总成交额9.32%。近5日资金流向一览见下表：凯莱英主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062900008179.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002821","BK1191","LU1328615791.USD","BK0239","06821","BK0132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647034208","title":"医药外包概念走强 昭衍新药(06127)涨9.16% 机构指相关标的业绩有望超预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2647034208","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647034208?lang=zh_cn&edition=full","pubTime":"2026-06-29 10:20","pubTimestamp":1782699626,"startTime":"0","endTime":"0","summary":"消息面上，东吴证券研究指，22家CXO上市公司2026Q1实现收入、归母净利润、扣非归母净利润总额增速分别同比增长18.6%、21.9%、63.5%，业绩逐季度改善。根据医药魔方，2026Q1，国内创新药一级市场融资总金额25.9亿美元，同比上涨128.6%，2026Q1中国相关交易数量及金额涨势迅猛，总金额达614亿美元，大幅领先国外交易总金额。该机构认为，随着中国创新药在全球研发创新中的比重提升，与其配套的CXO产业链将进一步增强。","market":"nz","thumbnail":"https://static.szfiu.com/news/20241108/ODBhOTU0MzI3NjMwOTM5MjE=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/ODBhOTU0MzI3NjMwOTM5MjE=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1984678","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03759","LU3063872942.SGD","01548","603127","06127","LU0359202008.SGD","LU0823426308.USD","LU0052750758.USD","BK0216","LU0348825331.USD","HK0000306685.HKD","BK1576","LU1046422090.SGD","BK1583","LU0320764599.SGD","LU2242644610.SGD","LU0043850808.USD","LU0140636845.USD","HK0000306701.USD","159938","09939","LU0326950275.SGD","LU0348767384.USD","LU0588546209.SGD","LU2045819591.USD","LU0348735423.USD","LU0708995583.HKD","LU1794554557.SGD","BK1161","LU2125910500.SGD","02359","LU1720050803.USD","LU0456846285.SGD","LU0417516738.SGD","LU1242518931.SGD","LU1688375341.USD","LU0181495838.USD","BK1141","LU0979878070.USD","BK1574","HK0000320223.HKD","03347","HK0000320264.USD","06821","BK1191","02269","LU0348766576.USD","LU0417516902.SGD","LU1880383366.USD","LU0516422952.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155558638","title":"一周港股牛熊榜 | 晋景新能绩后表现强劲！周内领涨逾26%、九方智投回购后涨逾20%；滔搏跌近30%，耐克渠道风波拖累股价","url":"https://stock-news.laohu8.com/highlight/detail?id=1155558638","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1155558638?lang=zh_cn&edition=full","pubTime":"2026-06-27 09:00","pubTimestamp":1782522007,"startTime":"0","endTime":"0","summary":"总结全周，恒生指数跌1252.95点或5.24%，恒生科技指数跌348.76点或7.57%。本周涨幅居前个股中，晋景新能因年度收入大增并实现扭亏为盈，股价累计上涨26.29%；九方智投控股受连续回购催化，本周累涨20.91%；首钢朗泽则因工业尾气生物合成无水乙醇项目取得进展，累计上涨20.49%。跌幅方面，博泰车联折价配售完成后股价承压，本周累计下跌35.31%；滔搏受耐克线上渠道传闻及一季度销售走弱拖累，累计下跌29.84%；曹操出行在AI出行、Robotaxi题材降温后回吐前期涨幅，本周累计下跌24.84%。","market":"hk","thumbnail":"https://static.tigerbbs.com/cb1639b5fc4982ccb82111d6af456d9b","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/cb1639b5fc4982ccb82111d6af456d9b"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"一周港股牛熊榜 | 晋景新能绩后表现强劲！周内领涨逾26%、九方智投回购后涨逾20%；滔搏跌近30%，耐克渠...","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02553","02643","02889","VXUS","02692","02382","09636","BK4588","06110","BK4585","02268","06821","01783"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2646332834","title":"港股异动 | CRO概念股逆市上扬 康龙化成(03759.HK)涨超4% 凯莱英(06821.HK)涨超3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2646332834","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646332834?lang=zh_cn&edition=full","pubTime":"2026-06-26 15:15","pubTimestamp":1782458104,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1141","03759","BK1191","BK1576","06821"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646806264","title":"股价异动，凯莱英称不存在应披露而未披露的重大事项","url":"https://stock-news.laohu8.com/highlight/detail?id=2646806264","media":"北京商报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646806264?lang=zh_cn&edition=full","pubTime":"2026-06-25 21:58","pubTimestamp":1782395929,"startTime":"0","endTime":"0","summary":"由于6月23日至6月25日连续3个交易日内收盘价格涨幅偏离值累计超过20％，触发股价异动标准，6月25日晚间，凯莱英（002821）披露了公司股票交易异常波动公告。公告显示，经查询，公司、控股股东、实际控制人不存在关于公司的应披露而未披露的重大事项，也不存在处于筹划阶段的其他重大事项。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202606253783373861.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606253783373861.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["002821","BK0239","06821","BK1191","LU1328615791.USD","BK0132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646722518","title":"凯莱英(06821.HK)A股股票交易异常波动 不存在应予以披露而未披露的事项","url":"https://stock-news.laohu8.com/highlight/detail?id=2646722518","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646722518?lang=zh_cn&edition=full","pubTime":"2026-06-25 19:19","pubTimestamp":1782386393,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["06821","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646754438","title":"凯莱英：连续3个交易日收盘价涨幅偏离值累超20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2646754438","media":"南方财经网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646754438?lang=zh_cn&edition=full","pubTime":"2026-06-25 17:04","pubTimestamp":1782378240,"startTime":"0","endTime":"0","summary":"南财智讯6月25日电，凯莱英发布股票交易异常波动公告，公司股票于2026年6月23日至2026年6月25日连续3个交易日内收盘价格涨幅偏离值累计超过20%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606253783130288.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1328615791.USD","BK1191","002821","BK0239","06821","BK0132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646455873","title":"6月25日凯莱英涨6.99%，中欧医疗健康混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2646455873","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646455873?lang=zh_cn&edition=full","pubTime":"2026-06-25 16:41","pubTimestamp":1782376913,"startTime":"0","endTime":"0","summary":"证券之星消息，6月25日凯莱英涨6.99%创60日新高，收盘报151.46元，换手率5.54%，成交量17.56万手，成交额25.78亿元。根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共67家，其中持有数量最多的公募基金为中欧基金的中欧医疗健康混合A。中欧医疗健康混合A目前规模为129.74亿元，最新净值1.6918，较上一交易日上涨3.89%，近一年上涨0.44%。中欧医疗健康混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062500029755.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["06821","BK1191","BK0132","002821","159760","LU1328615791.USD","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645952898","title":"凯莱英创60日新高，开源证券二个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2645952898","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645952898?lang=zh_cn&edition=full","pubTime":"2026-06-24 16:45","pubTimestamp":1782290722,"startTime":"0","endTime":"0","summary":"今日凯莱英创60日新高，收盘报141.57元。2026年4月1日，开源证券研究员余汝意发布了对凯莱英的研报《公司信息更新报告：收入利润高质增长，多赛道景气共振下迈向加速周期》，该研报对凯莱英给出“买入”评级。研报中预计2026-2028年公司归母净利润为15.07/18.59/23.12亿元，EPS为4.18/5.15/6.41元，当前股价对应PE为24.1/19.5/15.7倍，维持“买入”评级。凯莱英个股概况：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062400030244.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002821","161027","06821"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645898450","title":"6月24日凯莱英（002821）涨停分析：大额订单落地、FDA检查通过、自研新药获批驱动","url":"https://stock-news.laohu8.com/highlight/detail?id=2645898450","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645898450?lang=zh_cn&edition=full","pubTime":"2026-06-24 15:43","pubTimestamp":1782287007,"startTime":"0","endTime":"0","summary":"证券之星消息，凯莱英6月24日涨停收盘，收盘价141.57元。该股于9点50分涨停，未打开涨停，截止收盘封单资金为9980.97万元，占其流通市值0.22%。6月24日凯莱英涨停的可能因素有：公司于6月21日公告与某跨国药企签署超2亿美元新订单，涉及临床阶段ADC药物CDMO服务；同期披露其天津新基地已通过FDA现场检查，产能释放预期强化；另据6月上旬披露，其子公司获CDE批准首个自主申报的1类新药临床批件，标志平台能力向创新延伸。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062400023819.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002821","LU1328615791.USD","BK0132","BK1191","06821"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645866019","title":"CXO概念走强 凯莱英 (06821) 涨 17.77% BIO2026大会看好中国CXO高效率优势","url":"https://stock-news.laohu8.com/highlight/detail?id=2645866019","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645866019?lang=zh_cn&edition=full","pubTime":"2026-06-24 11:17","pubTimestamp":1782271026,"startTime":"0","endTime":"0","summary":"全球生物技术领域盛会BIO2026大会于6月22日至25日在美国圣地亚哥召开，汇聚全球超20000名行业参与者，覆盖人工智能与数字健康、细胞与基因治疗等前沿领域，中国CXO企业的高效率优势备受关注。光大证券研报指，2026年6月22日至25日BIO2026大会举办，70余个国家超2万名业内人士参会，覆盖18大生物医药核心议题，凯莱英、泰格医药、博腾股份等国内CXO企业参展，英硅智能同期落地AI药物研发海外合作。","market":"nz","thumbnail":"https://static.szfiu.com/news/20241108/ZDQyZmM0MDNhYTRlOWFhOWE0NDBjZGFmOTc4ZmU3NDQzMjc2MzA4MTk4NA==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/ZDQyZmM0MDNhYTRlOWFhOWE0NDBjZGFmOTc4ZmU3NDQzMjc2MzA4MTk4NA==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1984377","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000320264.USD","LU0326950275.SGD","LU1794554557.SGD","01548","06127","LU2242644610.SGD","LU0348735423.USD","LU0051755006.USD","LU0708995583.HKD","LU0856984785.SGD","LU0052750758.USD","LU1046422090.SGD","LU0516422952.EUR","BK0132","BK1583","LU0819121731.USD","LU0516422366.SGD","BK0239","LU1880383366.USD","SG9999002463.SGD","LU0359201612.USD","LU2039709279.SGD","002821","CXO","LU0039217434.USD","06821","HK0000306701.USD","LU0588546209.SGD","LU0359202008.SGD","LU1242518931.SGD","02269","LU0456827905.SGD","LU3063872942.SGD","03759","LU0348766576.USD","LU0572944931.SGD","LU0140636845.USD","LU0456846285.SGD","LU0327786744.USD","HK0000306685.HKD","02359","LU1328615791.USD","BK1576","LU0043850808.USD","LU1720050803.USD","BK1521","HK0000320223.HKD","03347","LU0320764599.SGD","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645866072","title":"CRO概念股震荡走高","url":"https://stock-news.laohu8.com/highlight/detail?id=2645866072","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645866072?lang=zh_cn&edition=full","pubTime":"2026-06-24 11:11","pubTimestamp":1782270685,"startTime":"0","endTime":"0","summary":"CRO概念股震荡走高","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202606243781168150.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606243781168150.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1576","03759","06821","BK1191","BK1583","03347","BK1141","06127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645865054","title":"CRO概念股早盘表现强势 凯莱英涨超14%金斯瑞生物科技涨超8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2645865054","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645865054?lang=zh_cn&edition=full","pubTime":"2026-06-24 10:35","pubTimestamp":1782268500,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n　　CRO概念股早盘表现强势，截至发稿，凯莱英（06821）上涨14.05%，报110.40港元；金斯瑞生物科技（01548）上涨8.56%，报11.80港元；药明康德（02359）上涨8.56%，报142港元；泰格医药（03347）上涨5.67%，报32.74港元。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：卢昱君","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2026-06-24/doc-inienpmx8299253.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1191","BK0239","BK1576","HK0000320223.HKD","HK0000306701.USD","01548","LU1328615791.USD","HK0000320264.USD","HK0000306685.HKD","BK1583","002821","BK0132","BK1141","06821"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645653708","title":"港股异动 | CRO概念股表现强势 BIO大会凸显中国CXO全球竞争力 医药领域开放迎来新突破","url":"https://stock-news.laohu8.com/highlight/detail?id=2645653708","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645653708?lang=zh_cn&edition=full","pubTime":"2026-06-24 10:00","pubTimestamp":1782266401,"startTime":"0","endTime":"0","summary":"消息面上，BIO 2026国际生物科技大会于6月22日至25日在美国圣地亚哥召开，中国CXO企业的高效率优势得到全球认可，海外订单拓展空间进一步打开。东方证券发布研报称，从CXO景气度关键指标的最新数据来看：2026年前五个月，国内资金端、研发端、订单端多重因素共振向上，国内CXO行业高景气持续。该行认为，国内CXO公司订单充足、量价双升，随着订单执行转化，将会带来报表端大幅改善。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1457906.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["159938","LU1169589451.USD","LU1046422090.SGD","HK0000306685.HKD","BK1515","LU0052750758.USD","LU0348766576.USD","LU2045819591.USD","HK0000320264.USD","BK1191","BK4121","BIO","BK1574","HK0000306701.USD","CXO","HK0000320223.HKD","LU0320764599.SGD","01548","LU0348767384.USD","02359","09939","LU0708995583.HKD","LU2125910500.SGD","BK1161","BK1141","BK1576","06821","VXUS","BK1583","BK4585","03347","LU1169590202.USD","LU2242644610.SGD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645865839","title":"港股医药外包概念股走强 凯莱英涨超9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2645865839","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645865839?lang=zh_cn&edition=full","pubTime":"2026-06-24 09:50","pubTimestamp":1782265829,"startTime":"0","endTime":"0","summary":"6月24日，港股医药外包概念股走强，截至发稿，凯莱英(06821.HK)涨超9%，金斯瑞生物科技(01548.HK)涨6.53%，泰格医药(03347.HK)涨5.04%，昭衍新药(06127.HK)涨5.13%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202606243780775996.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606243780775996.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0132","BK0239","LU1328615791.USD","BK1191","06821","159718","002821"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645386585","title":"CRO板块活跃","url":"https://stock-news.laohu8.com/highlight/detail?id=2645386585","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645386585?lang=zh_cn&edition=full","pubTime":"2026-06-24 09:35","pubTimestamp":1782264953,"startTime":"0","endTime":"0","summary":"CRO板块领涨，上涨1.87%，其中迦南科技上涨14.81%，凯莱英上涨3.62%，太龙药业上涨2.77%，药明康德、博腾股份、泰格医药涨超2%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202606243780700160.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606243780700160.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1583","BK1191","BK1141","BK1576","06821","03347"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.asymchem.com","stockEarnings":[{"period":"1week","weight":0.1395},{"period":"1month","weight":0.199},{"period":"3month","weight":0.0762},{"period":"6month","weight":0.5492},{"period":"1year","weight":0.4016},{"period":"ytd","weight":0.5492}],"compareEarnings":[{"period":"1week","weight":-0.0195},{"period":"1month","weight":-0.0914},{"period":"3month","weight":-0.0954},{"period":"6month","weight":-0.1073},{"period":"1year","weight":-0.0495},{"period":"ytd","weight":-0.1073}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"凯莱英医药集团（天津）股份有限公司是一家主要从事提供医药外包一站式综合服务的中国公司。该公司的业务包括小分子药物定制研发生产（CDMO）、化学大分子CDMO、临床研究服务、制剂CDMO、生物大分子CDMO、技术输出和合成生物技术。该公司的产品类别涵盖多肽、寡核苷酸、单克隆抗体、抗体偶联药物和信使RNA等。该公司主要在国内外市场开展其业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.058449},{"month":2,"riseRate":0.4,"avgChangeRate":0.006895},{"month":3,"riseRate":0.4,"avgChangeRate":0.004398},{"month":4,"riseRate":0.6,"avgChangeRate":-0.036171},{"month":5,"riseRate":0.4,"avgChangeRate":0.006805},{"month":6,"riseRate":0.6,"avgChangeRate":0.053806},{"month":7,"riseRate":0.5,"avgChangeRate":0.064859},{"month":8,"riseRate":0.25,"avgChangeRate":-0.064095},{"month":9,"riseRate":0.75,"avgChangeRate":0.163213},{"month":10,"riseRate":0,"avgChangeRate":-0.125552},{"month":11,"riseRate":0.5,"avgChangeRate":0.010601},{"month":12,"riseRate":0.25,"avgChangeRate":-0.010173}],"exchange":"SEHK","name":"凯莱英","nameEN":"ASYMCHEM"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"凯莱英(06821)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供凯莱英(06821)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"凯莱英,06821,凯莱英股票,凯莱英股票老虎,凯莱英股票老虎国际,凯莱英行情,凯莱英股票行情,凯莱英股价,凯莱英股市,凯莱英股票价格,凯莱英股票交易,凯莱英股票购买,凯莱英股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"凯莱英(06821)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供凯莱英(06821)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}